Seeking Alpha

Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate

RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc (IRD). (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of ...
TMCnet

Corteva Announces Executive Leadership Team of its Future Advanced Seed and Genetics Company

Corteva Inc. (NYSE: CTVA) announced today the executive leadership team that will lead "SpinCo," the publicly-traded, advanced seed and genetics company resulting from the current company's planned ...
Nasdaq

Myriad Genetics and Lumea Inc. Announce Integration of Advanced Molecular Diagnostic Tests into Digital Pathology Platform BxLink™

Myriad Genetics and Lumea Inc. partner to integrate molecular diagnostics into Lumea's digital pathology platform, enhancing cancer care efficiency. Myriad Genetics and Lumea Inc. have announced a ...
Seeking Alpha

NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment

SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc (MYGN). (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer ...